02-01-2010, 12:18 PM
Which of the following IS AN INDICATION TO START HAART TX?
a. CD4
a. CD4
WOTF is an indication to start HAART TX? - indored
|
02-01-2010, 12:18 PM
Which of the following IS AN INDICATION TO START HAART TX?
a. CD4
02-01-2010, 12:51 PM
this forum doesnt take less than sign, write it in words pls.
02-01-2010, 02:02 PM
cd4 less than 350
any count with symptoms pregnancy needle stick injury with known hiv positive patient
02-01-2010, 02:40 PM
+ viral load greater then 55000
02-01-2010, 03:52 PM
viral load is not the indicator for treatment.....it is helpful to guess how the treatment working i mean for follow up only
02-01-2010, 04:22 PM
nimish, you are right.
i am surprised to see how quickly it's updating all those !!!: updated: december 1, 2009 http://aidsinfo.nih.gov/contentfiles/Adu...centGL.pdf http://www.aidsinfo.nih.gov/Guidelines/G...Guidelines&Search=Off&GuidelineID=7&ClassID=1 Initiation of Antiretroviral Therapy: _________________________________________ In this updated version of the guidelines, the Panel recommends earlier initiation of antiretroviral therapy with the following specific recommendations: ¢ Antiretroviral therapy should be initiated in all patients with a history of an AIDS-defining illness or with CD4 count < 350 cells/mm3 (AI). ¢ Antiretroviral therapy should also be initiated, regardless of CD4 count, in patients with the following conditions: pregnancy (AI), HIV-associated nephropathy (AII), and hepatitis B virus (HBV) coinfection when treatment of HBV is indicated (AIII). ¢ Antiretroviral therapy is recommended for patients with CD4 counts between 350 and 500 cells/mm3. The Panel was divided on the strength of this recommendation: 55% of Panel members for strong recommendation (A) and 45% for moderate recommendation (B) (A/B-II). ¢ For patients with CD4 counts >500 cells/mm3, 50% of Panel members favor starting antiretroviral therapy (B); the other 50% of members view treatment as optional © in this setting (B/C-III). Patients initiating antiretroviral therapy should be willing and able to commit to lifelong treatment and should understand the benefits and risks of therapy and the importance of adherence (AIII). Patients may choose to postpone therapy, and providers, on a case-by-case basis, may elect to defer therapy based on clinical and/or psychosocial factors. Rating of Recommendations: A = Strong; B = Moderate; C = Optional Rating of Evidence: I = data from randomized controlled trials; II = data from well-designed nonrandomized trials or observational cohort studies with long-term clinical outcomes; III = expert opinion The primary goal of antiretroviral therapy is to reduce HIV-associated morbidity and mortali
02-01-2010, 04:34 PM
here is another ref:
if anybody feel to look for other purpose too: http://www.iasusa.org/guidelines/index.html |
« Next Oldest | Next Newest » |